Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-01

Clinical Trial Update: A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an investigational drug to prevent chemotherapy-induced diarrhea in previously untreated metastatic colorectal cancer has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational drug for diarrhea prevention

Snippet

Sponsor: Celgene Corporation | Conditions: Colorectal Neoplasms, Diarrhea | Phase 2 | Status: TERMINATED